Analyst picks & changes

Vertex Pharmaceuticals Inc.

(VRTX)

Vector Securities International analyst Gregory Brown initiated coverage with a "buy" and a one-year price target

Read the full 208 word article

How to gain access

Continue reading with a
two-week free trial.